BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31932754)

  • 1. Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment.
    Horikawa N; Abiko K; Matsumura N; Baba T; Hamanishi J; Yamaguchi K; Murakami R; Taki M; Ukita M; Hosoe Y; Koshiyama M; Konishi I; Mandai M
    Br J Cancer; 2020 Mar; 122(6):778-788. PubMed ID: 31932754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
    Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
    Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells.
    Horikawa N; Abiko K; Matsumura N; Hamanishi J; Baba T; Yamaguchi K; Yoshioka Y; Koshiyama M; Konishi I
    Clin Cancer Res; 2017 Jan; 23(2):587-599. PubMed ID: 27401249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
    Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
    Front Immunol; 2019; 10():183. PubMed ID: 30863394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Novel Ovarian Cancer Treatment Targeting Myeloid-Derived Suppressor Cells.
    Abiko K; Hayashi T; Yamaguchi K; Mandai M; Konishi I
    Cancer Invest; 2021 Apr; 39(4):310-314. PubMed ID: 33428503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock down of APE1 suppressed gastric cancer metastasis via improving immune disorders caused by myeloid-derived suppressor cells.
    Zhang B; Tang Q; Shi W; Bao Z; Gao S; Pan C
    Cell Cycle; 2024 Mar; 23(5):602-612. PubMed ID: 38717991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recombinant HMGB1 induces the differentiation of mouse myeloid cells into myeloid-derived suppressor cells in vitro].
    Su Z; Zhang Y; Ni P; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1362-1365. PubMed ID: 27667463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis.
    Sehgal R; Maiwall R; Rajan V; Islam M; Baweja S; Kaur N; Kumar G; Ramakrishna G; Sarin SK; Trehanpati N
    Front Immunol; 2022; 13():828949. PubMed ID: 35720398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer.
    Li W; Tanikawa T; Kryczek I; Xia H; Li G; Wu K; Wei S; Zhao L; Vatan L; Wen B; Shu P; Sun D; Kleer C; Wicha M; Sabel M; Tao K; Wang G; Zou W
    Cell Metab; 2018 Jul; 28(1):87-103.e6. PubMed ID: 29805099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity.
    Ruffolo LI; Jackson KM; Kuhlers PC; Dale BS; Figueroa Guilliani NM; Ullman NA; Burchard PR; Qin SS; Juviler PG; Keilson JM; Morrison AB; Georger M; Jewell R; Calvi LM; Nywening TM; O'Dell MR; Hezel AF; De Las Casas L; Lesinski GB; Yeh JJ; Hernandez-Alejandro R; Belt BA; Linehan DC
    Gut; 2022 Jul; 71(7):1386-1398. PubMed ID: 34413131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
    Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF
    J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF.
    Sun HW; Wu WC; Chen HT; Xu YT; Yang YY; Chen J; Yu XJ; Wang Z; Shuang ZY; Zheng L
    Front Immunol; 2020; 11():616367. PubMed ID: 33603745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
    Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
    Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of myeloid-derived suppressor cell differentiation ex vivo.
    Blanco E; Escors D; Kochan G
    Methods Cell Biol; 2024; 184():85-96. PubMed ID: 38555160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
    Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
    Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM-CSF-mediated inducement of bone marrow MDSCs by TSA and effect on survival of graft in mice.
    Zhao S; Li S; Yang J; Gao W; Chen Z
    Eur J Med Res; 2022 Aug; 27(1):161. PubMed ID: 36031660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
    Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
    Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Mll1-Complex by Stat3/Cebpβ-Induced miR-21a/21b/181b Maintains the Accumulation, Homeostasis, and Immunosuppressive Function of Polymorphonuclear Myeloid-Derived Suppressor Cells.
    Zhang Z; Huang X; Wang E; Huang Y; Yang R
    J Immunol; 2020 Jun; 204(12):3400-3415. PubMed ID: 32358019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.
    Roda JM; Sumner LA; Evans R; Phillips GS; Marsh CB; Eubank TD
    J Immunol; 2011 Aug; 187(4):1970-6. PubMed ID: 21765015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.
    Lechner MG; Liebertz DJ; Epstein AL
    J Immunol; 2010 Aug; 185(4):2273-84. PubMed ID: 20644162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.